Christopher J. Hasenberg »

Regeneron Pharmaceuticals shares owned by Christopher J. Hasenberg

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Christopher J. Hasenberg from 13F filings

Historical chart of Christopher J. Hasenberg investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Christopher J. Hasenberg consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Christopher J. Hasenberg

Quarter filed Position value Share count Share price at filing
2025-03-31 $6.2k 10 617.00
2024-12-31 $7.1k 10 712.30
2024-09-30 $10k 10 1005.30

More positions owned by Christopher J. Hasenberg

Schwab International Equity Etf Etf (SCHF)
Vanguard Growth Etf Etf (VUG)
Vanguard Mid-cap Etf Etf (VO)
Spdr Portfolio S&p 500 Value Etf Etf (SPYV)
Ishares Core S&p Small Cap Etf Etf (IJR)
Vanguard Ftse Emerging Markets Etf Etf (VWO)
Vanguard Value Etf Etf (VTV)
Schwab 5-10 Year Corporate Bond Etf Etf (SCHI)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)
Invesco Qqq Trust Series I Etf (QQQ)
Schwab U.s. Reit Etf Etf (SCHH)
Vanguard Mortgage-backed Securities Etf Etf (VMBS)
Ishares 20 Year Treasury Bond Etf Etf (TLT)
Spdr S&p Kensho New Economies Composite Etf Etf (KOMP)
Spdr Gold Shares Etf (GLD)

View all positions for Christopher J. Hasenberg

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Geode Capital Management
Franklin Resources
Capital World Investors
Loomis, Sayles and
FMR
Invesco
Susquehanna International
Morgan Stanley
Goldman Sachs Group
Nuveen

View all funds holding Regeneron Pharmaceuticals